SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

GOOGL is trending as investors digest the implications of a potential new browser from OpenAI, sparking debate about Google's dominance in search and advertising. The community is closely watching how this competition might impact Alphabet's revenue streams and market share, with some seeing it as a buying opportunity amidst the uncertainty. Despite concerns, analysts remain bullish, citing the company's strong position in AI and cloud computing.

WorldFinancial

WorldFinancial (WLFI) is trending as traders discuss its potential connection to political figures and real estate tokenization, creating a mix of excitement and skepticism. Community members are actively debating its long-term utility and speculating on upcoming news related to the borrowing feature and app. Despite some concerns about market manipulation, WLFI's low coin circulation and potential for a short squeeze are fueling bullish sentiment for a possible price surge.

Propy is a decentralized real-estate market place backed by superior blockchain infrastructure to facilitate real-time unified transaction in order to reduce fraud and redundancy. Propy is the world’s first international real-estate marketplace.

Propy

Propy ($PRO) is trending as traders discuss potential short squeezes and its potential as a real-world asset (RWA) project on the Ethereum blockchain. Community members are actively debating price movements, with some anticipating a run to $5, while others express skepticism and caution due to recent price volatility and concerns about large holders. The conversation also includes discussions about its utility in real estate transactions and possible partnerships.

Aptera Motors Corp. is an automotive technology company focused on the development, production, and distribution of energy-efficient, solar-powered, battery-electric vehicles. Its flagship product, the Aptera, is a three-wheeled, two-seat solar vehicle designed to reduce reliance on traditional charging by utilizing integrated solar panels. The company was founded by Steve Fambro and Chris Anthony and is headquartered in San Diego, CA.

Aptera Motors Corp - Ordinary Shares - Class B

Aptera Motors Corp

SEV is trending due to its recent direct listing and the subsequent volatile trading, with the community debating the company's valuation, technology, and design. A major point of contention is a lawsuit claiming Aptera doesn't own the design or intellectual property, while others focus on pre-order numbers and potential for disruption in the EV market. Bullish sentiment centers around the potential for solar EVs, while bears cite concerns about the company's financials and questionable machine free factory tours.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS is trending following an earnings beat and raised guidance, with analysts increasing price targets. The community is weighing the company's strategic positioning in healthcare, including its pharmacy and insurance segments, and whether it can maintain momentum given broader industry headwinds. Some traders are focused on technical indicators and options activity to gauge short-term price movements.

🔥 COCK Token – The Ultimate Cross-Chain MemeFi Powerhouse 🔥  In just under 20 days, $COCK has smashed expectations, broken ATHs, and built a project that’s shaking up Cardano and the entire crypto space. 🐓 What Makes $COCK Special?      The Name: Love it or hate it, the energy and engagement it generates are undeniable. The nuance in language and wild appeal set us apart.     #MEMEFI Pioneer: We’re not just another meme coin. $COCK is leading a movement by combining DeFi mechanics, game theory, and community engagement into a groundbreaking ecosystem.     COCKARENA: At the core of our ecosystem is the COCKARENA, a PvP HODL game. Players battle it out, and early exit fees fuel redistributions, burns, and the treasury. This ensures price appreciation and long-term sustainability for loyal holders.  🎰 The COCK Casino  Our casino isn’t just fun—it’s a serious revenue stream for the FLOCK.      Games: Bonanza, Crash, Blackjack, and Roulette (coming soon!).     Impact: Over 7,834 ADA in profits generated within days, directly supporting rewards, burns, and reinvestment.  💰 COCK-ARENA Loans  Unlock liquidity without selling your tokens.      Loan Terms: Borrow up to 30% of your holdings while continuing to earn rewards in the arena.     Investor Focus: Perfect for savvy investors staying in the game while tapping into their holdings.  🤝 Our Insane Partnerships  We’re bridging gaps, building alliances, and breaking barriers across the crypto space. Key Partners:      DANZO: Powering #MEMEFI with Arena, Casino, and Loans.     KLENEK: Interactive training room.     HSKN (Charles Hoskilien): Supporting and starting COCKPIN with 115 AIR NODES for DePIN aggregation. Plans to add APEX and Earth Nodes through a crypto company incorporated in Costa Rica.     ELITE CATS / SNEKKIES / HOT / BANK: Rewarding NFT holders with COCK-LOCK tokens and vice versa.     OCKZ: COCKSOCKS, Golden Cock Ticket (1M COCK), airdrop rewards, and whitelist perks for holders of 200 ADA worth of $COCK.     OLI Partnership:         Content Creation: Lux and the team are crafting engaging educational content about memes and MemeFi for OLi's platform.         Strategic Investment: The OLi Community Trust will invest in $COCK, distributing 100% of rewards to $OLI holders.         Community Reach: Over 22,000 learners will discover $COCK through OLi's gamified ecosystem.     Hi-Rez the Rapper: Expanding reach in marketing and entertainment.     KUNO, CALEB, CADEN, FITY, ROVER, WhaleInsider: Influential collaborators driving crypto adoption and growth.     Cardano Girls: Helping us understand and communicate effectively with ADA’s female audience.     WallStreetBets: Breaking barriers and increasing engagement.     Antonio Brown: Endorsing, supporting, and even playing in the casino and arena!     Advisors:         BERIS, HECKTHESNEK, RTB, CRYPTOGENIUS: Trusted names advising and supporting the project.  Future Partnerships:  More collaborations are in the pipeline to continue expanding engagement and bring new eyes to ADA and CNTs. 🔥 Unmatched Results in Just 20 Days      Supply Burned: 1.65%, worth 148K ADA!     Arena Fees Collected: 54M COCK, worth over 500K ADA, fueling rewards, burns, and partnerships.     Staked COCK-LOCK: 11M COCK-LOCK in the liquid staking platform, with more coming.     Casino Revenue: Skyrocketing profits directly rewarding holders and growing the treasury.     Top Blast Contests: Generated over 120K ADA in volume, rewarding participants with over 50K ADA in prizes.  🌍 Our Vision  To be the most decentralized, rewarding, and innovative token on Cardano while fostering cross-chain collaboration and onboarding the masses.      Breaking Barriers: We’re bringing BTC, ETH, SOL, and other chains into the fold.     Community-Driven: Focused on building bridges and showcasing that crypto can be fun, rewarding, and sustainable.     Expansion: This is just the beginning. With more burns, rewards, and partnerships on the way, $COCK is set to redefine what’s possible in the MemeFi space.  💎 Time in the arena > Timing the market. The FLOCK is unstoppable. Let’s keep breaking walls for Cardano and onboard new users as we take $COCK to new heights.

CockCardano

$COCK is trending due to its association with Cocky Wings, a real-world food truck business that fuels on-chain buybacks, and the community is actively discussing recent events and partnerships. Talk centers around staking in the $COCK Arena for passive income, the upcoming sale of Snek energy drinks, and a potential spicy hot sauce collaboration. The project's meme-driven approach combined with real-world utility seems to be resonating within the Cardano ecosystem.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

Hertz is trending as chatter around a potential short squeeze intensifies, fueled by high short interest and a new partnership with Amazon to sell used vehicles. Community members are actively discussing potential price targets and monitoring key technical indicators, while also weighing the company's debt against potential upside catalysts. Some investors are drawing parallels to Carvana's past performance, suggesting Hertz could see a similar surge.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as investors anticipate upcoming earnings, focusing on the potential impact of AI and Azure cloud growth on the company's direction. The community is actively discussing technical patterns, potential breakouts, and options strategies to capitalize on the expected movement. Broader discussions involve Microsoft's positioning within big tech and the competitive landscape of AI infrastructure.

BlackRock, Inc. engages in the provision of investment, advisory and risk management solutions. Its products include single-asset and multi-asset portfolios. The company was founded by Laurence Douglas Fink in 1988 and is headquartered in New York, NY.

Blackrock Inc.

BlackRock's earnings and AUM figures are generating significant buzz, though some analysts have cut their price targets, and a client withdrawal is adding to investor caution. Community members are discussing BlackRock's involvement in tokenization, potential acquisitions, and possible partnerships, especially with names like Kornit Digital and Beyond Meat. Option traders are actively analyzing potential entry and exit points, with some highlighting potential ROI on call options.

Medical Properties Trust, Inc. is a self-advised real estate investment trust. It engages in the investment, acquisition, and development of net-leased healthcare facilities. Its property portfolio includes rehabilitation hospitals, long-term acute care hospitals, ambulatory surgery centers, hospitals for women and children, regional and community hospitals, medical office buildings, and other single-discipline facilities. The company was founded by Edward K. Aldag Jr., R. Steven Hamner, Emmett E. McLean, and William Gilliard McKenzie in 2003 and is headquartered in Birmingham, AL.

Medical Properties Trust Inc

Medical Properties Trust is trending as investors discuss the potential for a short squeeze, fueled by high short interest and anticipation of positive catalysts. Community members are analyzing revenue trends and short-selling efficiency metrics, while also awaiting upcoming earnings reports and potential impacts from interest rate cuts. Discussions also include the company's asset sales and their effect on evaluations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wonder how ending the $11B US pharmaceutical advertising impacts small, medium and larger M&amp;A targets.  

Immediate cash increase on balance sheets, especially biggest spender AbbVie’s Skyrzi. 

20% of all US Television ads are Big Pharma.  Would be interesting to see how this companies with Asia / Europe. 

Bigger issue is how it impacts long term revenue, how funds get reapproiated. 

https://www.wsj.com/business/media/trumps-crackdown-on-drug-ads-could-sting-tv-networks-673c322a?st=sdcBQq&amp;reflink=article_copyURL_share

$DAWN $IFRX $ACLX $VKTX $MLTX

Ronald Baker

FlowerInTheCellar

nlrmandate

GMSinvest

StartSlow

STEVEN segal

StockTwits for iOS

Day One Biopharmaceuticals Inc

InflaRx N.V.

Arcellx Inc

Viking Therapeutics Inc

MoonLake Immunotherapeutics

Wonder how ending the $11B US pharmaceutical advertising impacts small, medium and larger M&A targets.  

Immediate cash increase on balance sheets, especially biggest spender AbbVie’s Skyrzi. 

20% of all US Television ads are Big Pharma.  Would be interesting to see how this companies with Asia / Europe. 

Bigger issue is how it impacts long term revenue, how funds get reapproiated. 



avalon E

@dogDazeSummer I think it will push more direct advertising to the prescribing community. Frankly, that&#39;s where it&#39;s most effective in a per dollar basis anyway. Mass general advertising to an unintelligent audience was never a great strategy to begin with if you look at return versus cost.

I can foresee the pharma industry repositioning far more funds into direct sales teams and promotional activities on the prescribing community. Folks sitting in doctors offices are going to see a far bigger push adverting strategy from the moment they enter the clinician&#39;s office.

We may also see increased profit with perhaps a small dip in total revenue as an industry in general.

In the end, the median age of the greater population is growing and so are the medical needs. The market itself will continue to grow relative to existing until we see the average age of the population start to recede which won&#39;t happen in our lifetime time.

 I think it will push more direct advertising to the prescribing community. Frankly, that's where it's most effective in a per dollar basis anyway. Mass general advertising to an unintelligent audience was never a great strategy to begin with if you look at return versus cost.

I can foresee the pharma industry repositioning far more funds into direct sales teams and promotional activities on the prescribing community. Folks sitting in doctors offices are going to see a far bigger push adverting strategy from the moment they enter the clinician's office.

We may also see increased profit with perhaps a small dip in total revenue as an industry in general.

In the end, the median age of the greater population is growing and so are the medical needs. The market itself will continue to grow relative to existing until we see the average age of the population start to recede which won't happen in our lifetime time.

K J Lays

@dogDazeSummer Don’t all those ads end with, ‘ask your doctor if drug X is right for you.’ 
 
Diseases are there nonetheless, the need for healthcare ever-increasing. 
 
I’ve started to wonder about the buying power of BP and their conflicts of interest.  As GPT notes, “Big pharma has already invested billions in TNF, IL-6, IL-17, JAK, and other cytokine-targeted platforms. These investments create both financial and cognitive inertia: teams, sales forces, manufacturing, regulatory expertise — all geared toward the ‘old bets.’ Partnering with or acquiring a potentially superior platform like C5a/C5aR could make some existing assets obsolete, cannibalizing their own revenue.” 
 
Terms of agreement with such a partner not so easy, likely more about disease/market restrictions than compensation.

StockTwits Web

 Don’t all those ads end with, ‘ask your doctor if drug X is right for you.’ 
 
Diseases are there nonetheless, the need for healthcare ever-increasing. 
 
I’ve started to wonder about the buying power of BP and their conflicts of interest.  As GPT notes, “Big pharma has already invested billions in TNF, IL-6, IL-17, JAK, and other cytokine-targeted platforms. These investments create both financial and cognitive inertia: teams, sales forces, manufacturing, regulatory expertise — all geared toward the ‘old bets.’ Partnering with or acquiring a potentially superior platform like C5a/C5aR could make some existing assets obsolete, cannibalizing their own revenue.” 
 
Terms of agreement with such a partner not so easy, likely more about disease/market restrictions than compensation.

@dogDazeSummer Perhaps better, initially, to partner with mid-sized pharmaceutical companies, more flexibility, less conflicts of interest.  US – Exelixis, PTC Therapeutics, Acadia Pharmaceuticals.  EU – UCB, Ipsen, Servier Laboratories. 
 
Then BP big-budget ad campaigns not an issue, especially for biotech that eventually sells itself.

 Perhaps better, initially, to partner with mid-sized pharmaceutical companies, more flexibility, less conflicts of interest.  US – Exelixis, PTC Therapeutics, Acadia Pharmaceuticals.  EU – UCB, Ipsen, Servier Laboratories. 
 
Then BP big-budget ad campaigns not an issue, especially for biotech that eventually sells itself.